In the U2OS osteosarcoma cells, PRMT6 has been shown to down regulate the expression of TSP-1 by introducing H3R2me2a modifications and reducing the active H3K4me3 modification in the TSP-1 promoter regions (Figure 3A). Here, THBS1 is linked to osteosarcoma.